cefuroxime has been researched along with Middle Ear Inflammation in 39 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We conducted two independent, investigator-blinded, multicenter, randomized clinical trials, one of which included microbiologic evaluation of middle ear fluid obtained by tympanocentesis, comparing the efficacy and safety of 5 or 10 days of treatment with cefuroxime axetil suspension (CAE) with that of 10 days of treatment with amoxicillin/clavulanate suspension (AMX/CL) in children with acute otitis media." | 9.08 | Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. ( Blair, E; Collins, JJ; Giguere, GG; Gooch, WM; Miller, HC; Paster, RZ; Puopolo, A; Schwartz, RH; Smyre, HL; Yetman, R, 1996) |
| "Cefuroxime axetil was evaluated for clinical efficacy and tolerance in the treatment of acute otitis media in children." | 9.07 | Cefuroxime axetil in the treatment of acute otitis media in children. ( Beratis, NG; Goumas, PD; Haliotis, FA; Lygatsikas, CG; Spyropoulos, CD; Syrogiannopoulos, GA, 1992) |
| "In this randomized, blinded, multicenter comparison study, 377 infants and children with acute otitis media (AOM) received a 10-day course of an oral suspension of one of the following: cefuroxime axetil (CAE), 30 mg/kg/day; cefaclor (CEC), 40 mg/kg/day; or amoxicillin-clavulanate potassium (AMX-CL), 40 mg/kg/day." | 9.06 | Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children. ( Aronovitz, GH; Darden, PM; Gooch, WM; Johnson, C; Maddern, B; McLinn, SE; Pichichero, M, 1990) |
| "We describe the case of an elderly woman with an episode of ambulatory de novo absence status epilepticus of late onset (DNASLO) after oral treatment with cefuroxime." | 7.88 | De novo absence status epilepticus of late onset (DNASLO) precipitated by oral treatment with cefuroxime: description of an ambulatory case. ( Fernández-Torre, JL; González-Aramburu, I; Hernández-Hernández, MA; López-Delgado, A; Martín-García, M; Paramio-Paz, A, 2018) |
| "To study the influence of resistance phenotypes (based on sentinel antibiotics: penicillin and amoxicillin with/without clavulanate) on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media." | 7.74 | Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. ( Aguilar, L; Coronel, P; Fenoll, A; Giménez, MJ; Gimeno, M; Granizo, JJ; Robledo, O; Tarragó, D, 2007) |
| "Amoxicillin, cefpodoxime and cefuroxime MICs remained low against numerous penicillin resistant strains, indicating that these three oral antibiotics (in combination with clavulanate for amoxicillin) have a useful potential for the treatment of acute otitis media when risk factors for pneumococcal penicillin-resistant infections are detected." | 7.70 | [Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996]. ( Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C, 1998) |
| "The comparative efficacies of amoxicillin and cefuroxime against acute otitis media caused by a penicillin-resistant (MIC, 2 micrograms/ml) Streptococcus pneumoniae strain were assessed in a gerbil model by challenging each ear with 10(7) bacteria through transbullar instillation." | 7.70 | In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 1998) |
| " The study was undertaken to determine the concentrations of cefuroxime in the blood and middle ear effusions (MEE) of children between 6 and 12 years of age with acute otitis media and chronic OME after a single oral dose administration of cefuroxime axetil, the ester prodrug of cefuroxime." | 7.68 | Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. ( Bluestone, CD; Collins, JJ; Haddad, J; Hart, RW; Isaacson, G; Respler, DS; Yilmaz, HM, 1991) |
| "Cefuroxime is a cephalosporin which is absorbed via the digestive tract in the form of cefuroxim-axetil." | 5.28 | [Activity of cefuroxime against bacterial strains isolated from acute otitis media]. ( Herrmann, JL; Simonet, M; Veron, M, 1990) |
| " We conducted two independent, investigator-blinded, multicenter, randomized clinical trials, one of which included microbiologic evaluation of middle ear fluid obtained by tympanocentesis, comparing the efficacy and safety of 5 or 10 days of treatment with cefuroxime axetil suspension (CAE) with that of 10 days of treatment with amoxicillin/clavulanate suspension (AMX/CL) in children with acute otitis media." | 5.08 | Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. ( Blair, E; Collins, JJ; Giguere, GG; Gooch, WM; Miller, HC; Paster, RZ; Puopolo, A; Schwartz, RH; Smyre, HL; Yetman, R, 1996) |
| " pneumoniae is associated with an impaired bacteriologic and clinical response of acute otitis media to cefaclor and cefuroxime axetil." | 5.08 | Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. ( Abramson, O; Dagan, R; Fliss, DM; Goshen, S; Greenberg, D; Lang, R; Leiberman, A; Leibovitz, E; Yagupsky, P, 1996) |
| "Bacteriologic response to cefuroxime axetil and cefaclor administered for 10 days was evaluated in acute otitis media (AOM) in patients aged 6-36 months." | 5.08 | Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? ( Abramson, O; Dagan, R; Fliss, DM; Goshen, S; Greenberg, D; Lang, R; Leiberman, A; Leibovitz, E; Yagupsky, P, 1997) |
| "Cefuroxime axetil was evaluated for clinical efficacy and tolerance in the treatment of acute otitis media in children." | 5.07 | Cefuroxime axetil in the treatment of acute otitis media in children. ( Beratis, NG; Goumas, PD; Haliotis, FA; Lygatsikas, CG; Spyropoulos, CD; Syrogiannopoulos, GA, 1992) |
| "In this randomized, blinded, multicenter comparison study, 377 infants and children with acute otitis media (AOM) received a 10-day course of an oral suspension of one of the following: cefuroxime axetil (CAE), 30 mg/kg/day; cefaclor (CEC), 40 mg/kg/day; or amoxicillin-clavulanate potassium (AMX-CL), 40 mg/kg/day." | 5.06 | Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children. ( Aronovitz, GH; Darden, PM; Gooch, WM; Johnson, C; Maddern, B; McLinn, SE; Pichichero, M, 1990) |
| " As an example, a study comparing 5 days of cefuroxime axetil therapy with either 10 days of cefuroxime axetil or amoxycillin/clavulanate showed no differences in rates of clinical cure, bacteriological eradication and recurrence in paediatric patients with either acute otitis media or sinusitis." | 4.80 | Short courses of antibiotic in acute otitis media and sinusitis infections. ( Pichicero, M, 2000) |
| " Metaanalyses of clinical trials demonstrate that uncomplicated acute otitis media in children can be successfully treated with a 5-day course of cefuroxime axetil." | 4.80 | Short-course antibiotic therapy for infections with a single causative pathogen. ( Adam, D, 2000) |
| "We describe the case of an elderly woman with an episode of ambulatory de novo absence status epilepticus of late onset (DNASLO) after oral treatment with cefuroxime." | 3.88 | De novo absence status epilepticus of late onset (DNASLO) precipitated by oral treatment with cefuroxime: description of an ambulatory case. ( Fernández-Torre, JL; González-Aramburu, I; Hernández-Hernández, MA; López-Delgado, A; Martín-García, M; Paramio-Paz, A, 2018) |
| " We report a 14-month-old girl who presented with rectal prolapse complicated with Clostridium difficile-associated pseudomembranous colitis after a 4-day course of oral cefuroxime for treatment of acute otitis media." | 3.77 | Rectal prolapse in a child: an unusual presentation of Clostridium difficile-associated pseudomembranous colitis. ( Huang, SC; Lee, CT; Yang, YJ, 2011) |
| "To study the influence of resistance phenotypes (based on sentinel antibiotics: penicillin and amoxicillin with/without clavulanate) on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media." | 3.74 | Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. ( Aguilar, L; Coronel, P; Fenoll, A; Giménez, MJ; Gimeno, M; Granizo, JJ; Robledo, O; Tarragó, D, 2007) |
| "The comparative efficacies of amoxicillin and cefuroxime against acute otitis media caused by a penicillin-resistant (MIC, 2 micrograms/ml) Streptococcus pneumoniae strain were assessed in a gerbil model by challenging each ear with 10(7) bacteria through transbullar instillation." | 3.70 | In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 1998) |
| "The efficacy of amoxicillin/clavulanate and cefuroxime was determined in a gerbil model of otitis media with a mixed Streptococcus pneumoniae plus Haemophilus influenzae middle ear (ME) infection." | 3.70 | Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model. ( Aguilar, L; Cenjor, C; García-Calvo, G; Giménez, MJ; Nieto, E; Parra, A; Ponte, C; Soriano, F, 2000) |
| " Children over 2 are treated by amoxicillin or CG1, children with conjunctivitis are treated by amoxicillin + clavulanate acid, infants attending day care centers and with recent history of antibiotic treatment have to be treated by cefuroxim-axetil, cefpodoximproxetil or high dosages of amoxicillin." | 3.70 | [Treatment of acute otitis media in children]. ( François, M, 1998) |
| "Amoxicillin, cefpodoxime and cefuroxime MICs remained low against numerous penicillin resistant strains, indicating that these three oral antibiotics (in combination with clavulanate for amoxicillin) have a useful potential for the treatment of acute otitis media when risk factors for pneumococcal penicillin-resistant infections are detected." | 3.70 | [Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996]. ( Fremaux, A; Georges, S; Geslin, P; Sissia, G; Spicq, C, 1998) |
| "Eighty-four children suffering from acute otitis media caused by Streptococcus pneumoniae were treated prospectively with cefuroxime axetil suspension (30 mg/kg of body weight twice daily for 8 days)." | 3.69 | In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media. ( Berche, P; Gehanno, P; Lenoir, G, 1995) |
| " The study was undertaken to determine the concentrations of cefuroxime in the blood and middle ear effusions (MEE) of children between 6 and 12 years of age with acute otitis media and chronic OME after a single oral dose administration of cefuroxime axetil, the ester prodrug of cefuroxime." | 3.68 | Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. ( Bluestone, CD; Collins, JJ; Haddad, J; Hart, RW; Isaacson, G; Respler, DS; Yilmaz, HM, 1991) |
| "All sultamicillin-treated and all but three cefuroxime axetil-treated patients experienced cure or improvement; only one cefuroxime axetil-treated patient discontinued treatment due to treatment failure." | 2.67 | An open multicentre study to compare the efficacy and safety of sultamicillin with that of cefuroxime axetil in acute ear nose and throat infections in adults. ( Alvart, R, 1992) |
| " Although guidelines continue to endorse amoxicillin as the preferred treatment, amoxicillin/clavulanate in high dosage would be the preferred treatment based on the otopathogen mix currently." | 2.49 | Otitis media. ( Pichichero, ME, 2013) |
| " For amoxicillin and amoxicillin/clavulanate, the target was free antibiotic concentration remaining above the minimum inhibitory concentration (MIC) for ≥50% of the dosing interval (fT>MIC≥50%), whereas for cefuroxime axetil and cefotaxime, the target was fT>MIC≥60%." | 1.51 | Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine. ( Canut-Blasco, A; Ibar-Bariain, M; Isla, A; Rodríguez-Gascón, A; Solinís, MA, 2019) |
| "Early treatment of profound bilateral sensorineural hearing loss with cochlear implantation has become routine, resulting in an increased proportion of children implanted at younger ages." | 1.39 | The management of acute mastoiditis in children with cochlear implants: saving the device. ( Cushing, SL; Gordon, KA; James, AL; Osborn, HA; Papsin, BC, 2013) |
| "Acute mastoiditis is the most frequent intratemporal complication of otitis media." | 1.32 | Acute mastoiditis caused by Moraxella catarrhalis. ( Jero, J; Leskinen, K, 2003) |
| "To know the variability of treatment of acute otitis media in Spain and the appropriateness of such with respect to consensus." | 1.31 | The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments. ( Ochoa, C; Pérez Méndez, C; Solís, G, 2000) |
| " Bacterial numbers were reduced by 3 log10 cfu/mL during the eight-hour experimental period with both dosage form simulations." | 1.28 | Killing kinetics of cefuroxime axetil against Haemophilus influenzae in an in-vitro model simulating serum concentration profiles after oral administration. ( Bingen, E; Doit, C; Duvignaud, P; Georges, D; Lambert-Zechovsky, N; Mariani-Kurkdjian, P, 1991) |
| "Cefuroxime is a cephalosporin which is absorbed via the digestive tract in the form of cefuroxim-axetil." | 1.28 | [Activity of cefuroxime against bacterial strains isolated from acute otitis media]. ( Herrmann, JL; Simonet, M; Veron, M, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.13) | 18.7374 |
| 1990's | 19 (48.72) | 18.2507 |
| 2000's | 11 (28.21) | 29.6817 |
| 2010's | 7 (17.95) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Torre, JL | 1 |
| Paramio-Paz, A | 1 |
| López-Delgado, A | 1 |
| Martín-García, M | 1 |
| González-Aramburu, I | 1 |
| Hernández-Hernández, MA | 1 |
| Ibar-Bariain, M | 1 |
| Rodríguez-Gascón, A | 1 |
| Isla, A | 1 |
| Solinís, MA | 1 |
| Canut-Blasco, A | 1 |
| Pichichero, ME | 1 |
| Osborn, HA | 1 |
| Cushing, SL | 1 |
| Gordon, KA | 1 |
| James, AL | 1 |
| Papsin, BC | 1 |
| Al-Mazrou, KA | 1 |
| Shibl, AM | 1 |
| Kandeil, W | 1 |
| Pirçon, JY | 1 |
| Marano, C | 1 |
| Weiss, I | 1 |
| Marom, T | 1 |
| Goldfarb, A | 1 |
| Roth, Y | 1 |
| Huang, SC | 1 |
| Yang, YJ | 1 |
| Lee, CT | 1 |
| Leskinen, K | 1 |
| Jero, J | 1 |
| Helms, D | 1 |
| Roberge, RJ | 1 |
| Kovalick, M | 1 |
| Jacobs, MR | 1 |
| Good, CE | 1 |
| Sellner, T | 1 |
| Bajaksouzian, S | 1 |
| Windau, A | 1 |
| Anon, JB | 1 |
| Fenoll, A | 1 |
| Aguilar, L | 3 |
| Robledo, O | 1 |
| Giménez, MJ | 3 |
| Tarragó, D | 1 |
| Granizo, JJ | 1 |
| Gimeno, M | 1 |
| Coronel, P | 1 |
| Glynn, F | 1 |
| Skinner, LJ | 1 |
| Daly, CA | 1 |
| Donnelly, M | 1 |
| Martini, A | 1 |
| Xerri, L | 1 |
| Gehanno, P | 1 |
| Lenoir, G | 1 |
| Berche, P | 1 |
| Dagan, R | 3 |
| Shvartzman, P | 1 |
| Liss, Z | 1 |
| Liston, TE | 1 |
| Gooch, WM | 2 |
| Blair, E | 1 |
| Puopolo, A | 1 |
| Paster, RZ | 1 |
| Schwartz, RH | 1 |
| Miller, HC | 1 |
| Smyre, HL | 1 |
| Yetman, R | 1 |
| Giguere, GG | 1 |
| Collins, JJ | 2 |
| Abramson, O | 2 |
| Leibovitz, E | 2 |
| Lang, R | 2 |
| Goshen, S | 2 |
| Greenberg, D | 2 |
| Yagupsky, P | 2 |
| Leiberman, A | 2 |
| Fliss, DM | 2 |
| Joseph, EM | 1 |
| Sperling, NM | 1 |
| Cenjor, C | 2 |
| Ponte, C | 2 |
| Parra, A | 2 |
| Nieto, E | 2 |
| García-Calvo, G | 2 |
| Soriano, F | 2 |
| Olszewski, J | 2 |
| Zalewski, P | 1 |
| Markucki, S | 1 |
| Schmidt, J | 1 |
| Preston, D | 1 |
| Therasse, D | 1 |
| Zeckel, ML | 1 |
| Geslin, P | 1 |
| Fremaux, A | 1 |
| Sissia, G | 1 |
| Spicq, C | 1 |
| Georges, S | 1 |
| Ogle, JW | 1 |
| Adam, D | 1 |
| Pichicero, M | 1 |
| Solís, G | 1 |
| Ochoa, C | 1 |
| Pérez Méndez, C | 1 |
| Lund, B | 1 |
| Edlund, C | 1 |
| Rynnel-Dagöö, B | 1 |
| Lundgren, Y | 1 |
| Sterner, J | 1 |
| Nord, CE | 1 |
| François, M | 1 |
| Kuśmierczyk, K | 1 |
| Syrogiannopoulos, GA | 1 |
| Goumas, PD | 1 |
| Haliotis, FA | 1 |
| Lygatsikas, CG | 1 |
| Spyropoulos, CD | 1 |
| Beratis, NG | 1 |
| Alvart, R | 1 |
| Bingen, E | 1 |
| Lambert-Zechovsky, N | 1 |
| Doit, C | 1 |
| Duvignaud, P | 1 |
| Georges, D | 1 |
| Mariani-Kurkdjian, P | 1 |
| Haddad, J | 1 |
| Isaacson, G | 1 |
| Respler, DS | 1 |
| Hart, RW | 1 |
| Yilmaz, HM | 1 |
| Bluestone, CD | 1 |
| Pichichero, M | 1 |
| Aronovitz, GH | 1 |
| McLinn, SE | 1 |
| Maddern, B | 1 |
| Johnson, C | 1 |
| Darden, PM | 1 |
| Simonet, M | 1 |
| Herrmann, JL | 1 |
| Veron, M | 1 |
| Lildholdt, T | 1 |
| Felding, JU | 1 |
| Juul, A | 1 |
| Kristensen, S | 1 |
| Schouenborg, P | 1 |
4 reviews available for cefuroxime and Middle Ear Inflammation
| Article | Year |
|---|---|
Otitis media.
Topics: Age Factors; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bact | 2013 |
Management of otitis media. A review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxim | 1995 |
Short-course antibiotic therapy for infections with a single causative pathogen.
Topics: Anti-Bacterial Agents; Bronchitis; Cefuroxime; Cephalosporins; Drug Administration Schedule; Humans; | 2000 |
Short courses of antibiotic in acute otitis media and sinusitis infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Clavulanic Acid; Drug Administration | 2000 |
9 trials available for cefuroxime and Middle Ear Inflammation
| Article | Year |
|---|---|
Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Child; Child, | 1996 |
Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Drug Re | 1996 |
Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Female; | 1997 |
Cefaclor and cefuroxime axetil in the treatment of otitis media--an alternative view.
Topics: Biomarkers; Cefaclor; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Prodrugs; Random Allo | 1998 |
Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; Cefuroxime; Cephalosp | 2001 |
Cefuroxime axetil in the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Cefuroxime; Child; Child, Preschool; Female; Humans; Male; Otitis Media; | 1992 |
An open multicentre study to compare the efficacy and safety of sultamicillin with that of cefuroxime axetil in acute ear nose and throat infections in adults.
Topics: Adult; Ampicillin; Bacterial Infections; Cefuroxime; Drug Therapy, Combination; Humans; Otitis Media | 1992 |
Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children.
Topics: Acoustic Impedance Tests; Acute Disease; Administration, Oral; Amoxicillin; Amoxicillin-Potassium Cl | 1990 |
Efficacy of perioperative ceftazidime in the surgical treatment of chronic otitis media due to Pseudomonas aeruginosa. Preliminary report of a prospective, controlled study.
Topics: Adult; Ceftazidime; Cefuroxime; Clinical Trials as Topic; Female; Humans; Male; Otitis Media; Prospe | 1986 |
26 other studies available for cefuroxime and Middle Ear Inflammation
| Article | Year |
|---|---|
De novo absence status epilepticus of late onset (DNASLO) precipitated by oral treatment with cefuroxime: description of an ambulatory case.
Topics: Age of Onset; Aged; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Epilepsy, Absence; Female; Hu | 2018 |
Application of pharmacokinetic/pharmacodynamic analysis to evaluate the adequacy of antimicrobial therapy for pediatric acute otitis media in Spain before and after the introduction of the PCV7 vaccine.
Topics: Algorithms; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefur | 2019 |
The management of acute mastoiditis in children with cochlear implants: saving the device.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefprozil; Cefu | 2013 |
A prospective, observational, epidemiological evaluation of the aetiology and antimicrobial susceptibility of acute otitis media in Saudi children younger than 5years of age.
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Child, Preschool; Drug Resistance, Mul | 2014 |
Luc's abscess: the return of an old fellow.
Topics: Abscess; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Earache; Fusobacterium In | 2010 |
Rectal prolapse in a child: an unusual presentation of Clostridium difficile-associated pseudomembranous colitis.
Topics: Anti-Bacterial Agents; Cefuroxime; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female | 2011 |
Acute mastoiditis caused by Moraxella catarrhalis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Female; Gram-Negative Bacterial | 2003 |
Otomastoiditis-related facial nerve palsy.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefuroxime; Child; Facial Nerve Diseases; Facial Pa | 2003 |
Nasopharyngeal carriage of respiratory pathogens in children undergoing pressure equalization tube placement in the era of pneumococcal protein conjugate vaccine use.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Cephalosporin Resistance; Child; Child, Preschool; Dr | 2007 |
Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefuroxime; Cephalosp | 2007 |
Otogenic pneumocephalus: case report and review of the literature.
Topics: Aged; Anti-Infective Agents; Cefuroxime; Drug Therapy, Combination; Earache; Female; Humans; Injecti | 2007 |
Study of diffusion of cefuroxime into middle ear effusions of patients with chronic purulent otitis media.
Topics: Cefuroxime; Cephalosporins; Diffusion; Ear, Middle; Humans; Otitis Media; Otitis Media, Suppurative | 1982 |
In vivo correlates for Streptococcus pneumoniae penicillin resistance in acute otitis media.
Topics: Acute Disease; Cefuroxime; Child, Preschool; Humans; Infant; Microbial Sensitivity Tests; Otitis Med | 1995 |
Variation in acceptance of common oral antibiotic suspensions.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Child, Preschool; Fe | 1994 |
Facial nerve paralysis in acute otitis media: cause and management revisited.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Age | 1998 |
In vivo efficacies of amoxicillin and cefuroxime against penicillin-resistant Streptococcus pneumoniae in a gerbil model of acute otitis media.
Topics: Acute Disease; Amoxicillin; Animals; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; | 1998 |
[Zinnat in ambulatory treatment of acute pharyngitis and otitis media in adult patients].
Topics: Acute Disease; Adult; Ambulatory Care; Cefuroxime; Cephalosporins; Female; Humans; Male; Otitis Medi | 1997 |
[Development of resistance to beta-lactams and other antibiotics of pneumococci isolated from acute otitis media in France: statement of the National Reference Center 1995-1996].
Topics: Acute Disease; Amoxicillin; beta-Lactam Resistance; beta-Lactams; Cefpodoxime; Ceftizoxime; Cefuroxi | 1998 |
Role of Streptococcus pneumoniae and Haemophilus influenzae in the development of acute otitis media and otitis media with effusion in a gerbil model.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Animals; Cefuroxime; Cephalosporins; C | 2000 |
Antimicrobial therapy for ambulatory pediatrics.
Topics: Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefuroxime; Cephalexin; Cep | 1999 |
The variability and appropriateness of the antibiotic prescription of acute otitis media in childhood. The Spanish Study Group for Antibiotic Treatments.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ce | 2000 |
[Treatment of acute otitis media in children].
Topics: Acute Disease; Age Factors; Amoxicillin; Analgesics; Analgesics, Non-Narcotic; Anti-Bacterial Agents | 1998 |
[Therapeutic efficacy assessment of cefuroxime axetil in short 4 day course of empirical antibiotic therapy in patients with bacterial infections of upper respiratory tract and otitis media].
Topics: Acute Disease; Administration, Oral; Adult; Cefuroxime; Cephalosporins; Drug Administration Schedule | 2001 |
Killing kinetics of cefuroxime axetil against Haemophilus influenzae in an in-vitro model simulating serum concentration profiles after oral administration.
Topics: Administration, Oral; Adult; Capsules; Cefuroxime; Child; Haemophilus influenzae; Humans; Kinetics; | 1991 |
Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil.
Topics: Acute Disease; Administration, Oral; Cefuroxime; Child; Chronic Disease; Exudates and Transudates; F | 1991 |
[Activity of cefuroxime against bacterial strains isolated from acute otitis media].
Topics: Cefuroxime; Cephalosporins; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive | 1990 |